WallStreetZenWallStreetZen

NASDAQ: ARQT
Arcutis Biotherapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Arcutis Biotherapeutics revenue was $196.54M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $71.4M, up 59.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ARQT annual revenue was $196.5M, with 229.7% growth year-over-year.

ARQT past revenue growth

How has ARQT's revenue growth performed historically?

Company
229.74%
Industry
437.31%
Market
20.27%
ARQT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ARQT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ARQT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ARQT revenue history

Current Revenue
$196.5M
Current Earnings
-$140.0M
Current Profit Margin
-71.3%

Be the first to know when ARQT announces revenue.

ARQT Revenue History By Year

ARQT Yearly RevenueARQT RevenueARQT ChangeARQT Revenue Growth
2024-12-31$196.54M$136.94M+229.74%
2023-12-31$59.61M$55.92M+1,517.09%
2022-12-31$3.69MN/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A

1 of 1

Arcutis Biotherapeutics Revenue FAQ

What was ARQT's revenue last quarter?

On Invalid Date, Arcutis Biotherapeutics (NASDAQ: ARQT) reported Q4 2024 revenue of $71.36 million up 427.58% year over year. In the same quarter last year, Arcutis Biotherapeutics's revenue was $13.53 million.

What was Arcutis Biotherapeutics's revenue in 2024?

Arcutis Biotherapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $196.54 million, a 229.74% increase year over year.

How much does Arcutis Biotherapeutics make in a day?

Based on Arcutis Biotherapeutics annual revenue for the past five years, ARQT makes an average of $142,374.79 per day.

What was Arcutis Biotherapeutics's annual revenue growth in the past year?

As of Q2 2025, Arcutis Biotherapeutics's revenue has grown 229.74% year over year. This is 207.57 percentage points lower than the US Biotechnology industry revenue growth rate of 437.31%. Arcutis Biotherapeutics's revenue in the past year totaled $196.54 million.

How much does Arcutis Biotherapeutics make in a year?

Arcutis Biotherapeutics's revenue by year for the past five years is:
  • Arcutis Biotherapeutics's revenue for the twelve months ending Dec 31, 2024 was $196.54 million, a 229.74% increase year over year.
  • Arcutis Biotherapeutics's annual revenue for Dec 31, 2023 was $59.61 million, a 1,517.09% increase from 2022.
  • Arcutis Biotherapeutics's annual revenue for 2022 was $3.69 million, a Infinity% increase from 2021.
  • Arcutis Biotherapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Arcutis Biotherapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.